SkinHealth Systems Inc.
SKIN
$0.65
$0.000.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -6.71% | -1.35% | -10.34% | -13.70% | -14.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.71% | -1.35% | -10.34% | -13.70% | -14.52% |
| Cost of Revenue | -2.52% | 26.70% | -34.42% | -41.44% | -36.44% |
| Gross Profit | -8.52% | -12.11% | 12.26% | 19.96% | 0.45% |
| SG&A Expenses | -24.27% | -12.16% | -17.82% | -18.31% | -4.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.25% | -0.54% | -23.35% | -28.23% | -17.07% |
| Operating Income | 85.02% | -80.78% | 70.99% | 87.79% | 29.24% |
| Income Before Tax | 25.97% | 58.97% | 34.87% | 12,496.69% | -587.89% |
| Income Tax Expenses | -120.63% | 337.46% | -80.18% | -181.30% | 235.36% |
| Earnings from Continuing Operations | 34.33% | 21.55% | 39.69% | 9,658.42% | -1,386.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.33% | 21.55% | 39.69% | 9,658.42% | -1,386.89% |
| EBIT | 85.02% | -80.78% | 70.99% | 87.79% | 29.24% |
| EBITDA | 160.33% | -25.52% | 118.32% | 120.47% | 29.77% |
| EPS Basic | 30.98% | 23.37% | 41.04% | 9,675.00% | -1,367.27% |
| Normalized Basic EPS | 16.74% | -26.88% | 36.33% | 103.51% | 48.02% |
| EPS Diluted | 30.98% | 23.37% | 40.00% | 129.17% | 15.23% |
| Normalized Diluted EPS | 18.91% | -26.88% | 36.33% | 103.65% | 38.99% |
| Average Basic Shares Outstanding | 2.17% | 2.44% | 2.28% | 1.90% | 1.59% |
| Average Diluted Shares Outstanding | 5.05% | 2.44% | 2.28% | -1.15% | -13.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |